Kodiak's Q2 Loss Wider Than Expected, Pipeline Development in Focus Zacks Equity Research Aug 14, 2026 KOD's Zenkuda advances toward regulatory submission as its pipeline gains momentum. Key clinical data is expected later in 2026.
KOD Begins Late-Stage Study of KSI-501 in Diabetic Macular Edema Zacks Equity Research Aug 11, 2026 Kodiak launches a global phase III study of KSI-501 in DME, testing its dual IL-6 and VEGF approach for durable disease control.